Literature DB >> 31722239

Chair-side saliva diagnostic tests: An evaluation tool for xerostomia and caries risk assessment in children with type 1 diabetes.

Eftychia Pappa1, Heleni Vastardis2, Christos Rahiotis3.   

Abstract

OBJECTIVES: The aim of this cross-sectional study was to investigate how the level of metabolic control affects salivary function, xerostomia prevalence and incidence of caries, in children and adolescents with type 1 diabetes.
METHODS: For the purpose of this study, a total of 150 children and adolescents (10-18 years old) were examined and allocated among 3 groups: 50 patients poorly-controlled (HbA1c≥7.5%), 50 well-controlled (HbA1c<7.5%) and 50 age- and sex-matched healthy controls. All subjects were examined for dental caries, oral hygiene and salivary factors. Assessments of salivary characteristics included self-reported xerostomia, quantification of resting and stimulated whole saliva flow rates, pH values, buffering capacity and saliva's viscosity. A questionnaire and a chair-side saliva testing kit were used for the evaluation of salivary function. Caries incidence was recorded using DMFT index. Plaque index and gingival index were additionally evaluated. Data were analysed by Chi-square and Kruskal-Wallis tests.
RESULTS: Higher caries levels, higher prevalence of xerostomia and a decreased unstimulated salivary flow rate were recorded in poorly-controlled diabetics. The average caries indexes were DMFT(poor c) 3.6, DMFT(well c)1.2, DMFT(healthy) 1.5, p < 0.05). Salivary status and caries index were not found to be significantly different between well-controlled patients and healthy controls.
CONCLUSIONS: The results of this study indicated that chair-side salivary tests provide the practitioners with an easy-to use and quick method for the evaluation of salivary function and caries risk assessment in young patients with diabetes. CLINICAL SIGNIFICANCE: The use of chair-side salivary tests provide the practitioners with an easy-to use and quick method for caries risk assessment and confirmation of clinical symptoms and signs in young patients with diabetes. They could be easily incorporated into daily office routine and may provide a useful tool for screening at risk patients and a simple way to communicate with the patients the need for further interventions for prevention.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Caries; Children; Saliva; Type 1 diabetes; Xerostomia

Year:  2019        PMID: 31722239     DOI: 10.1016/j.jdent.2019.103224

Source DB:  PubMed          Journal:  J Dent        ISSN: 0300-5712            Impact factor:   4.379


  5 in total

1.  Salivary levels of hBDs in children and adolescents with type 1 diabetes mellitus and gingivitis.

Authors:  Dogukan Yilmaz; Neslihan Yilmaz; Recep Polat; Verneri Nissilä; Elif Gül Aydın; Jaana Rautava; Mervi Gürsoy; Ulvi Kahraman Gürsoy
Journal:  Clin Oral Investig       Date:  2022-03-21       Impact factor: 3.606

2.  Downregulation of Salivary Proteins, Protective against Dental Caries, in Type 1 Diabetes.

Authors:  Eftychia Pappa; Konstantinos Vougas; Jerome Zoidakis; William Papaioannou; Christos Rahiotis; Heleni Vastardis
Journal:  Proteomes       Date:  2021-07-19

3.  Comparative Evaluation of Chair-Side Saliva Tests According to Current Dental Status in Adult Patient.

Authors:  Chris Rahiotis; Panagiotis Mitropoulos; Afrodite Kakaboura
Journal:  Dent J (Basel)       Date:  2021-01-19

4.  Predicting dental caries increment using salivary biomarkers in a remote Indigenous Australian child population.

Authors:  Surani Fernando; Santosh Tadakamadla; Jeroen Kroon; Ratilal Lalloo; Newell W Johnson
Journal:  BMC Oral Health       Date:  2021-07-23       Impact factor: 2.757

Review 5.  Interplay Among the Oral Microbiome, Oral Cavity Conditions, the Host Immune Response, Diabetes Mellitus, and Its Associated-Risk Factors-An Overview.

Authors:  Thais de Cássia Negrini; Iracilda Zeppone Carlos; Cristiane Duque; Karina Sampaio Caiaffa; Rodrigo Alex Arthur
Journal:  Front Oral Health       Date:  2021-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.